The court determined that a preliminary injunction was “an extraordinary remedy with clear requirements that Plaintiffs do not currently meet,” noting that in all of the states in the action, mifepristone remained available to prescribe and the FDA hadn’t made any indication that it intended to limit access to the drug.


CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.